Related Experiment Video
Updated: Jul 12, 2026

Scanning Electron Microscopy of Macerated Tissue to Visualize the Extracellular Matrix
Published on: June 14, 2016
Structural analysis of obscurin gene in hypertrophic cardiomyopathy
Takuro Arimura1, Yuji Matsumoto, Osamu Okazaki
1Department of Molecular Pathogenesis, Medical Research Institute and Laboratory of Genome Diversity, School of Biomedical Science, Tokyo Medical and Dental University, 2-3-10 Kandasurugadai, Chiyoda-ku, Tokyo 101-0062, Japan.
Insights
Genetic mutations in the obscurin gene (OBSCN) may contribute to hypertrophic cardiomyopathy (HCM). A specific variant, Arg4344Gln, was found to disrupt obscurin
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Basis of Cardiac Diseases
Background:
- Hypertrophic cardiomyopathy (HCM) is a genetic cardiac condition marked by left ventricular hypertrophy and diastolic dysfunction.
- While mutations in sarcomere/Z-band protein genes explain about half of HCM cases, novel disease genes require identification.
- Obscurin (OBSCN) interacts with titin/connectin, a known HCM-associated protein, making it a candidate for investigation.
Purpose of the Study:
- To investigate the role of obscurin gene (OBSCN) mutations in the pathogenesis of hypertrophic cardiomyopathy (HCM).
Main Methods:
- Screening of HCM patients for mutations in the obscurin gene (OBSCN).
- Functional analysis of identified OBSCN variants, including Arg4344Gln and Ala4484Thr, focusing on titin/connectin binding and Z-band localization.
- Utilizing Myc-tagged obscurin for assessing Z-band localization.
Main Results:
- Two linked variants, Arg4344Gln and Ala4484Thr, were identified in an HCM patient.
- The Arg4344Gln variant impaired the binding of obscurin to the Z9-Z10 domains of titin/connectin.
- The Arg4344Gln variant also disrupted the proper localization of obscurin to the Z-band.
Conclusions:
- Obscurin gene (OBSCN) abnormalities, particularly the Arg4344Gln variant, may play a role in the development of hypertrophic cardiomyopathy (HCM).
- Disruption of obscurin-titin/connectin interaction and Z-band localization are potential mechanisms underlying HCM pathogenesis.
- Further research into OBSCN as a causative gene for HCM is warranted.
Abstract:
Hypertrophic cardiomyopathy (HCM) is a cardiac disease characterized by left ventricular hypertrophy with diastolic dysfunction. Molecular genetic studies have revealed that HCM is caused by mutations in genes for sarcomere/Z-band components including titin/connectin and its associate proteins. However, disease-causing mutations can be found in about half of the patients, suggesting that other disease-causing genes remain to be identified. To explore a novel disease gene, we searched for obscurin gene (OBSCN) mutations in HCM patients, because obscurin interacts with titin/connectin. Two linked variants, Arg4344Gln and Ala4484Thr, were identified in a patient and functional analyses demonstrated that Arg4344Gln affected binding of obscurin to Z9-Z10 domains of titin/connectin, whereas Ala4484Thr did not. Myc-tagged obscurin showed that Arg4344Gln impaired obscurin localization to Z-band. These observations suggest that the obscurin abnormality may be involved in the pathogenesis of HCM.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Structure of Cardiac Muscles
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...
Cardiomyopathy I: Introduction and Classification
Coronary Artery Disease II: Pathophysiology

